NEW YORK - Johnson & Johnson, the world's most diverse maker of health care products, is "a good defensive 'safe-haven' in this time of broader market volatility," RBC Capital Markets analyst Ryan Bachman recently wrote in a note to investors.
The company is expected to post higher third-quarter earnings Tuesday, partly due to savings from a restructuring program. Sales for certain key products are faltering due to the economic downturn, generic competition and other issues, but Bachman says J&J will likely plan for growth through acquisitions.
Analysts surveyed by Thomson Financial expect J&J to post earnings of $1.11 per share, compared with a profit of $1.06 per share a year earlier.
You've heard the talk of "Green" throughout the whole of 2008, bu...
South Korea said Tuesday it will invest 50 trillion won ($38.1 billion) over the next four years on environmental projects in a "Green New D...
The pullback to 1.2070 was quite deep but this resistance capped as expected but we really need a break below 1.1755 to sustain the move lower no...
AdMob, the world's largest and fastest growing mobile advertising marketplace, today la...


Buy Real Estate, Tax Liens, and more- Fund your business or franchise without debt
Get your next web design project done with our los angeles web design team - Best web design with great price.
Building your business and corporate credit for your small business.